May 25 coronavirus news

By Helen Regan, Melissa Macaya, Melissa Mahtani, Meg Wagner and Veronica Rocha, CNN

Updated 8:08 p.m. ET, May 25, 2021
11 Posts
Sort byDropdown arrow
10:26 a.m. ET, May 25, 2021

Americans don’t trust people outside their close circle to be honest about vaccination status, poll finds

From CNN’s Naomi Thomas

Americans don’t trust people who are outside of their close circle to be honest about whether they’ve been vaccinated against Covid-19, according to new poll results from Axios-Ipsos published Tuesday. 

The poll found that 71% of respondents had a great deal or fair amount of trust in their coworkers to be honest about their vaccination status, and 88% felt this way about their family and close friends. The poll was conducted between May 21 to 24 and made up of a nationally representative sample of 1,102 US adults.

Trust was a lot lower when it came to groups outside of friends and family. 

Only 38% were likely to trust people outside their close circle. People in public settings were even less likely to be trusted, such as outdoor sporting events or concerts (25%), indoor restaurants and bars (25%) and airports (24%) 

Democrats were less likely to trust people to be honest than Republicans and Americans overall, especially when it came to trusting people who were opposed to taking the vaccine. Thirty-one percent of Americans overall trusted those who were opposed to the vaccine to be honest about if they were vaccinated, including 47% of Republicans and only 19% of Democrats. 

9:28 a.m. ET, May 25, 2021

White House expects US to reach 50% adults fully vaccinated today 

From CNN's Kaitlan Collins

Medical Assistant Odilest Guerrier administers a Moderna COVID-19 vaccine to Marie Val at a clinic in Immokalee, Florida, on May 20.
Medical Assistant Odilest Guerrier administers a Moderna COVID-19 vaccine to Marie Val at a clinic in Immokalee, Florida, on May 20. Joe Raedle/Getty Images

The White House expects the US will reach a new milestone when it comes to vaccinations today with 50% of adults now fully vaccinated. Officials are expected to tout the numbers during today's coronavirus briefing at 1:30 p.m. ET, CNN has learned. 

As of Monday, the US was at 49.8% of adults fully vaccinated, according to US Centers for Disease Control and Prevention data reviewed by CNN's Deidre McPhillips. That means nearly 131 million people are fully vaccinated against Covid-19. 

Earlier this month, President Biden said he wanted 160 million US adults fully vaccinated by July 4. 

8:22 a.m. ET, May 25, 2021

Moderna says its Covid-19 vaccine is safe and appears effective in adolescents

From CNN's John Bonifield

Boxes of the Moderna COVID-19 vaccine are seen in freezers at Kedren Community Health Center in Los Angeles, California, on May 13.
Boxes of the Moderna COVID-19 vaccine are seen in freezers at Kedren Community Health Center in Los Angeles, California, on May 13. Jay L. Clendenin/Los Angeles Times/Getty Images

Moderna says its vaccine is safe and appears to be effective at preventing Covid-19 in adolescents.

In a Phase 2/3 trial of 3,732 children ages 12 to 17 in the United States, blood tests showed that the vaccine produced an immune response that was equivalent to earlier findings in adults 

The company did not provide an efficacy number as the trial wasn't designed to look specifically at efficacy. However, initial observations found that none of the children who received the vaccine got sick with Covid-19 starting 14 days after their second dose. Four of the children who received the placebo tested positive for Covid-19, which Moderna says is "consistent with a vaccine efficacy of 100%." The company notes that figure could change as more data is collected.

The company also reviewed how well the vaccine worked after just one dose. The results suggest that after one dose, the vaccine was 93% effective at preventing mild cases of Covid-19, involving only one symptom instead of two or more symptoms.

Moderna announced the results Tuesday in a news release, and the results have not yet been peer reviewed or published

The company said the vaccine was "generally well tolerated" and no significant safety concerns have been identified. Side effects included headache, fatigue, muscle pain and chills after administration of the second dose. Pain at the injection site was also sometimes observed.

Moderna says it plans to submit the results to the US Food and Drug Administration in early June along with a request for authorization to use the vaccine in adolescents. It also plans to submit the data to a peer-reviewed publication.

The Moderna vaccine is already authorized for use in people age 18 and older. Another Covid-19 vaccine – one made by Pfizer/BioNTech – is authorized for use in people age 12 and older.

4:34 a.m. ET, May 25, 2021

Delhi leader says Indian government vaccine procurement policies are "a joke"

From CNN’s Esha Mitra in New Delhi and CNN’s Amanda Sealy

Delhi’s deputy chief minister said the Indian central government's vaccine rollout is “a joke," saying international companies including Pfizer have declined their separate requests for vaccines. 

“What kind of a joke is being made of vaccines,” Delhi’s deputy chief minister Manish Sisodia said in an online address Monday, while discussing the central government's efforts at vaccine procurement and distribution. 

“If we ask the central government for vaccines from Indian companies, they say they will give us only 4 lakh (400,000 doses),” Sisodia said. The population of Delhi was more than 11 million in the last census in 2011.

Sisodia added that when state governments went directly to foreign companies, they were told the companies were negotiating with the federal government instead.

The deputy chief minister claimed Moderna and Pfizer had declined the local government's requests for vaccinations, saying they would not sell to individual states. 

In a statement to CNN, Pfizer said the company would continue to engage with the Indian government on making their vaccine available for use in India.

“During the pandemic phase, across the world Pfizer is supplying the Covid-19 vaccine only to central Governments and supra-national organizations for deployment in the countries’ national immunization programs," the statement said.

"The allocation of doses and implementation plan within a country is a decision for local governments based on relevant health authority guidance.”

Moderna has not yet responded to CNN’s request for comment. 

Sisodia questioned why India is still dependent solely on two domestically-made vaccines, which were exported without first catering to in-country demand. 

“Why are vaccines not available, where did they go? I have said many times the central government is to blame for this," Sisodia said.

"If the country is forced to deal with the brunt of corona it's because the central government has completely failed in vaccine management."


3:46 a.m. ET, May 25, 2021

Taiwan extends second-highest Covid-19 alert level for three more weeks

From CNN's Eric Cheung in Taipei, Taiwan

A soldier disinfects his fellow worker after a sanitization operation in Taipei, Taiwan on May 24.
A soldier disinfects his fellow worker after a sanitization operation in Taipei, Taiwan on May 24. Annabelle Chih/SOPA Images/LightRocket/Getty Images

Taiwan has extended its second-highest Covid-19 alert level for three more weeks until June 14, the Central Epidemic Command Center (CECC) announced today, as the island battles its biggest coronavirus outbreak since the start of the pandemic last year.

The level 3 alert requires people to wear masks at all times in public and prohibits indoor gatherings of more than five people. The restrictions will be applicable across the island, said Taiwan's Health Minister Chen Shih-chung.

All students have been asked to take lessons remotely until June 14.

Chen added that Taiwan is expected to receive two million doses of Covid-19 vaccines in June, though he did not specify which vaccines the island would receive.

The extension comes as Taiwan reported 281 new local Covid-19 cases on Tuesday, Chen said. A total of 49 of those cases were reported in capital Taipei, while 154 were reported in New Taipei City -- a region in northern Taiwan that surrounds the capital.

In addition, more than 261 Covid-19 cases were found to have been left out of the total count in previous days due to reporting delays, causing the CECC to revise up Taiwan's final number of infections.

After the revision, Taiwan has confirmed 5,456 Covid-19 cases. The island reported six more deaths from Covid-19 on Tuesday, bringing the total death toll since the beginning fo the pandemic to 35.

9:10 a.m. ET, May 25, 2021

Covid-19 variant first detected in India is now the most dominant mutant variant in the country

From CNN’s Esha Mitra in New Delhi

Data on genome sequencing shared during a Covid-19 review by the Indian Minister of Health indicates that B.1.617 is the most dominant mutant variant in India. 

Out of 25,739 positive Covid-19 samples sequenced, the variant B.1.617 was found in 5,261 of them, making it "the most common mutation detected till now,” the Indian Ministry of Health and Family Welfare said in a statement Monday.

In March, India's health ministry said the Covid-19 variant which was first detected in the UK was the most prevalent in the country. But B.1.617 has since grown in prevalence following the second wave which has torn through the country.  

India has not only been struggling with an increasing number of mutant variants, but also a strain of infections of "black fungus" -- a rare and potentially deadly disease called mucormycosis.

Many of those being infected with the "black fungus" are coronavirus patients, or those who have recently recovered from Covid-19, meaning their immune systems have been weakened by the virus.

Based on an analysis of 5,424 cases of black fungus reported in the country, 4,556 cases had a history of Covid-19 infections. Health minister Harsh Vardhan on Monday said 55% of those affected also had diabetes, leaving them more vulnerable to the disease. 

The latest figures from the Ministry of Chemicals and Fertilizers said there are at least 8,848 cases of black fungus in the country. 

Read more on black fungus here:

9:10 a.m. ET, May 25, 2021

India reports 196,000 Covid-19 cases — the lowest single-day rise in over a month

From CNN’s Esha Mitra in New Delhi

A health worker collects a nasal swab sample in a mobile testing van in Amritsar, India on May 24.
A health worker collects a nasal swab sample in a mobile testing van in Amritsar, India on May 24. Narinder Nanu/AFP/Getty Images

India reported 196,427 new cases of Covid-19 on Tuesday, the lowest single-day rise in cases since April 14, according to a CNN tally of figures from the Indian Ministry of Health.

This marks a decline from the first week of May when the country was reporting more than 300,000 cases daily. 

India also reported 3,511 fatalities on Tuesday, the lowest single-day death toll since May 4, according to a CNN tally of figures from the Indian Ministry of Health. On Monday, India became the third country to top 300,000 deaths from the virus, after Brazil and the United States. 

The Indian Ministry of Health said Monday that the weekly positivity rate had declined to 12.6%, and 72% of the country’s active cases were being reported from eight states.

However, the director of the National Center for Disease Control, Sujeet Singh, warned the growth rate of cases continues to be “a matter of concern," according to a news release from the health ministry.

India has reported a total of 26,948,874 Covid-18 cases, including 307,231 deaths. There are 2,586,782 confirmed active cases in the country, according to the health ministry.

1:22 a.m. ET, May 25, 2021

São Paulo announces measures to prevent spread of Covid-19 variant first identified in India

From journalist Fernanda Wenzel in Porto Alegre, Brazil

Tietê bus station on March 19 in Sao Paulo, Brazil.
Tietê bus station on March 19 in Sao Paulo, Brazil. Rodrigo Paiva/Getty Images

São Paulo's government on Monday announced plans to restrict the coronavirus variant first identified in India from reaching Brazil’s most populous metropolis, after one confirmed case and other suspected infections were detected in the country's northeast. 

Symptomatic passengers coming through the Tietê bus station, one of the busiest in the country, will be sent to hospital facilities for Covid-19 tests, a city government statement said. Symptomatic truck drivers traveling on highways will also be tested. 

The move follows a news conference held this weekend by Brazilian Health Minister Marcelo Queiroga, who announced measures aimed at preventing the spread of the B.1.617 variant in the hopes of preventing community transmission. 

The federal government’s first measure was to send 600,000 rapid tests to the northeastern state of Maranhão, where the first case of the new variant was detected in Brazil.

The patient is a 54-year-old man who was aboard a ship that traveled to Brazil from Malaysia. The patient has been hospitalized in São Luís, Maranhão's capital, since May 14.

According to Queiroga, the tests will be used on passengers in airports and at the state’s borders. "Any passenger with a positive rapid test will have to take a RT-PCR test with genomic research to verify the Indian variant,” the minister said. 

The same strategy will be replicated in Guarulhos, Brazil’s busiest airport, in the state of São Paulo, and on the main roads and bus terminals in Rio de Janeiro and São Paulo.

Last week, the Brazilian government banned flights coming from or transiting through India, the United Kingdom, Northern Ireland or South Africa from entering the country. 

In addition to Maranhão, one suspected case of the variant first identified in India is being investigated in the state of Ceará, also in the northeast region, and two cases are under investigation in the state of Pará, in the north of Brazil, according to statements from those state governments.

12:41 a.m. ET, May 25, 2021

WHO team pinpoints overlooked Chinese data for further study, source says

From CNN's Nick Paton Walsh

Previously overlooked Chinese data on extensive screening of animals for coronavirus around the time the pandemic erupted is among several areas identified for further study by World Health Organization (WHO) scientists investigating the origins of Covid-19, a source close to the team told CNN.

The source said the records are contained in a nearly 200-page annex posted alongside the WHO panel's March report that received little attention among global experts at the time. But the data may add weight to calls from China's critics for more transparency and to the WHO team's desire to return to the country for further studies.

No date has been set for the team's return to China, but the source said any future visit to the country -- where the virus emerged in the city of Wuhan, Hubei province, in late 2019 -- may involve "smaller groups supporting specific studies first." A larger group, similar to the 17 international experts that visited in January, might then follow up, the source added.

The WHO report's annex contains multiple data points providing an intriguing insight into China's evolving knowledge of the virus and the likely timing of its emergence.

It provides details of China's storage and destruction of positive Covid-19 samples from humans; a significant influenza outbreak that emerged in December 2019, at the same time as the virus; and the revelation that the first people known to have contracted the virus had contact with a total of 28 separate food and animal markets in December.

Read the full story: